Adverse event totals18

The totals the trial posted for each group.

1 to 18 of 18

Total	Group	Affected	At risk
Total, all-cause mortality	Baseline Gabapentin 1800 mg
Total, all-cause mortality	GEn 1200 mg
Total, all-cause mortality	Crossover GEn 2400 mg
Total, all-cause mortality	GEn 3600 mg
Total, all-cause mortality	Down-Titration Period
Total, all-cause mortality	Overall GEn
Total, other adverse events	Baseline Gabapentin 1800 mg	2	94
Total, other adverse events	GEn 1200 mg	15	91
Total, other adverse events	Crossover GEn 2400 mg	3	82
Total, other adverse events	GEn 3600 mg	14	85
Total, other adverse events	Down-Titration Period	2	80
Total, other adverse events	Overall GEn	27	94
Total, serious adverse events	Baseline Gabapentin 1800 mg	0	94
Total, serious adverse events	GEn 1200 mg	0	91
Total, serious adverse events	Crossover GEn 2400 mg	0	82
Total, serious adverse events	GEn 3600 mg	0	85
Total, serious adverse events	Down-Titration Period	1	80
Total, serious adverse events	Overall GEn	1	94

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00617461/event-totals